Safety and efficacy of the addition of pertuzumab to T-DM1 ± taxane in patients with HER2-positive, locally advanced or metastatic breast cancer: a pooled analysis

Jing Zhang1 Cancer Center, West China Hospital, Collaborative Innovation Center for Biotherapy;2 Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu

Jinying Li3 The Second Affiliated Hospital of Medical College of Qingdao University, Qingdao Central Hospital, Qingdao, People’s Republic of China

Chenjing Zhu1 Cancer Center, West China Hospital, Collaborative Innovation Center for Biotherapy

Yanlin Song1 Cancer Center, West China Hospital, Collaborative Innovation Center for Biotherapy

Fan Xia1 Cancer Center, West China Hospital, Collaborative Innovation Center for Biotherapy

Xuelei Ma1 Cancer Center, West China Hospital, Collaborative Innovation Center for BiotherapyCorrespondence[email protected]

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Safety and efficacy of the addition of pertuzumab to T-DM1 ± taxane in patients with HER2-positive, locally advanced or metastatic breast cancer: a pooled analysis

Articles from other publishers (2)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Safety and efficacy of the addition of pertuzumab to T-DM1 ± taxane in patients with HER2-positive, locally advanced or metastatic breast cancer: a pooled analysis

Citations (2)

Articles from other publishers (2)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date